Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter …

MS Nash, JE Lewis, TA Dyson-Hudson… - Archives of physical …, 2011 - Elsevier
Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS Nash, JE Lewis, TA Dyson-Hudson… - Archives of Physical …, 2011 - archives-pmr.org
Abstract Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen
AM, Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS Nash, JE Lewis, TA Dyson-Hudson… - Archives of physical …, 2011 - scholarship.miami.edu
Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter …

MS Nash, JE Lewis, TA Dyson-Hudson, Y Szlachcic… - 2011 - pubmed.ncbi.nlm.nih.gov
Objective To test the safety, tolerance, and efficacy of extended-release niacin monotherapy
on dyslipidemia in persons with chronic tetraplegia. Design Placebo-controlled, blinded …

Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS Nash, JE Lewis, TA Dyson-Hudson… - Archives of Physical …, 2011 - infona.pl
Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

[PDF][PDF] Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS Nash, JE Lewis, TA Dyson-Hudson… - Arch Phys Med …, 2011 - researchgate.net
Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter …

MS Nash, JE Lewis, TA Dyson-Hudson… - Archives of Physical …, 2011 - europepmc.org
Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. - Abstract …

[引用][C] Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS NASH, JE LEWIS… - Archives of physical …, 2011 - pascal-francis.inist.fr
Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating
Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized Multicenter …

[PDF][PDF] Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS Nash, JE Lewis, TA Dyson-Hudson… - Arch Phys Med …, 2011 - academia.edu
Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …

Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized …

MS Nash, JE Lewis, TA Dyson-Hudson… - Archives of physical …, 2011 - scholarship.miami.edu
Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, Spungen AM,
Bauman WA. Safety, tolerance, and efficacy of extended-release niacin monotherapy for …